Omalizumab as a Provoking Factor for Venous Thromboembolism

A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain. Computed tomography pulmonary angiography showed bila...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Target Insights
Prif Awduron: Oblitas, Crhistian-Mario, Galeano-Valle, Francisco, Vela-De La Cruz, Laura, Del Toro-Cervera, Jorge, Demelo-Rodríguez, Pablo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2019
Pynciau:
Letter to the Editor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611017/
https://ncbi.nlm.nih.gov/pubmed/31320796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1177392819861987
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg